Phase 2 study to evaluate combination therapy in patients with metastatic colorectal cancer, targeting β-catenin-driven immune exclusion in liver ...

Colorectal cancer is one of the most common types of tumor and is responsible for around 10% of cancer-related deaths worldwide. The tumor is particularly dangerous when it forms metastases—i.e.

UAB Medicine offers liver transplantation as a treatment for metastatic colorectal cancer, expanding access to advanced ...

GLP-1 receptor agonists may help mitigate progression of at least some obesity-related cancers, according to retrospective ...

NSCLC showed the largest reduction in metastatic progression with GLP-1RAs versus gliptins (HR 0.50), with significant ...

A randomized phase III trial of the impact of a structured exercise program on disease-free survival (DFS) in stage 3 or high-risk stage 2 colon cancer: Canadian Cancer Trials Group (CCTG) CO.21 ...

Please provide your email address to receive an email when new articles are posted on . Aspirin did not improve DFS for individuals with colorectal cancer liver metastases compared with placebo. OS ...

Adagene (NASDAQ:ADAG) Chief Strategy Officer Mickael Chane-Du outlined the company's clinical strategy for its lead antibody program, ADG126, during a discussion with Stifel senior biotech analyst ...

Exelixis, Inc. (Nasdaq: EXEL) today announced that the company has entered into a clinical development collaboration with Merck, known as MSD outside of the United States and Canada, to supply ...